JP5923469B2 - エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 - Google Patents

エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 Download PDF

Info

Publication number
JP5923469B2
JP5923469B2 JP2013167198A JP2013167198A JP5923469B2 JP 5923469 B2 JP5923469 B2 JP 5923469B2 JP 2013167198 A JP2013167198 A JP 2013167198A JP 2013167198 A JP2013167198 A JP 2013167198A JP 5923469 B2 JP5923469 B2 JP 5923469B2
Authority
JP
Japan
Prior art keywords
estrogen
composition
acetate
testosterone
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2013167198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015036368A5 (enExample
JP2015036368A (ja
Inventor
一之 篠原
一之 篠原
裕和 土居
裕和 土居
正太 西谷
正太 西谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOTHER & CHILD CO., LTD.
Original Assignee
MOTHER & CHILD CO., LTD.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOTHER & CHILD CO., LTD. filed Critical MOTHER & CHILD CO., LTD.
Priority to JP2013167198A priority Critical patent/JP5923469B2/ja
Priority to PCT/JP2014/068676 priority patent/WO2015022831A1/ja
Publication of JP2015036368A publication Critical patent/JP2015036368A/ja
Publication of JP2015036368A5 publication Critical patent/JP2015036368A5/ja
Application granted granted Critical
Publication of JP5923469B2 publication Critical patent/JP5923469B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
JP2013167198A 2013-08-10 2013-08-10 エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。 Expired - Fee Related JP5923469B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2013167198A JP5923469B2 (ja) 2013-08-10 2013-08-10 エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。
PCT/JP2014/068676 WO2015022831A1 (ja) 2013-08-10 2014-07-14 エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013167198A JP5923469B2 (ja) 2013-08-10 2013-08-10 エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。

Publications (3)

Publication Number Publication Date
JP2015036368A JP2015036368A (ja) 2015-02-23
JP2015036368A5 JP2015036368A5 (enExample) 2015-06-25
JP5923469B2 true JP5923469B2 (ja) 2016-05-24

Family

ID=52468221

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013167198A Expired - Fee Related JP5923469B2 (ja) 2013-08-10 2013-08-10 エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。

Country Status (2)

Country Link
JP (1) JP5923469B2 (enExample)
WO (1) WO2015022831A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020007261A (ja) * 2018-07-06 2020-01-16 株式会社マザー＆チャイルド 女性用のテストステロン分泌を増進させるテストステロン分泌増進用組成物、芳香治療用組成物、芳香治療用入浴剤、芳香治療用食品、及び、芳香治療用具

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0923908A2 (pt) * 2008-12-30 2015-08-04 Basf Se Dispensador para feromônios, e, processo para produzir um dispensador.

Also Published As

Publication number Publication date
JP2015036368A (ja) 2015-02-23
WO2015022831A1 (ja) 2015-02-19

Similar Documents

Publication Publication Date Title
Malcolm et al. Essential oil of lavender in anxiety disorders: Ready for prime time?
Clarkson et al. Controversies about HRT—lessons from monkey models
JP2003265445A (ja) 哺乳動物におけるストレスまたはリラクセーションのレベルの測定方法
Inaba et al. Human body odor: etiology, treatment, and related factors
KR20030067595A (ko) 수면 및 수면-관련 거동에 영향을 주는 방법
JP5116942B2 (ja) プロジェステロンの変化に伴う不快症状の改善用組成物、及びその芳香治療用組成物、並びにその芳香治療用具
Matsubara et al. Inhalation of Japanese cedar (Cryptomeria japonica) wood odor causes psychological relaxation after monotonous work among female participants
TW201041603A (en) Fragrance composition having good sleep-inducing effect
US20020146469A1 (en) Methods for reducing chronic stress in mammals
JP5923468B2 (ja) エストロジェン分泌増進用組成物、及びその芳香組成物、並びにその芳香用具。
JP5923469B2 (ja) エストロジェン及びテストステロン分泌増進用組成物、及びその芳香用組成物、並びにその芳香用具。
JP4805589B2 (ja) エストロゲン様作用剤
JP2008247894A (ja) ストレス応答力改善剤
JP2018179603A (ja) 心理、神経、内分泌、免疫指標を用いた香りの生理心理効果の評価方法
Clarós et al. Why the olfactory acuity to Exaltolide test is different in women?
JP2024069378A (ja) 老化によって引き起こされる女性の障害を緩和するためのサプリメント
JP2020007261A (ja) 女性用のテストステロン分泌を増進させるテストステロン分泌増進用組成物、芳香治療用組成物、芳香治療用入浴剤、芳香治療用食品、及び、芳香治療用具
JP7162856B2 (ja) 更年期女性用のエストロジェン分泌を増進させる芳香治療用組成物、芳香治療用入浴剤、芳香治療用食品、及び、芳香治療用具
Inaba et al. Human body odor
JP2006282509A (ja) 抑うつ気分の改善用組成物
US20090075964A1 (en) Fragrance compositions and other compositions which contain naturally occurring substances found in corals
JP2021134159A (ja) エストロジェン分泌増進用組成物
Turlier et al. A Well‐Tolerated Hair Serum Containing New Natural Active Ingredients Reduced Hair Loss and Improved Quality of Life in Women With Chronic Telogen Effluvium: A 16‐Week Controlled Study
CN102905704B (zh) 交感神经抑制剂以及含有该抑制剂的化妆品、食品和杂货
KR20190024618A (ko) 팔마로사 오일을 포함하는 에센셜 오일 조성물 및 멀티모달 생체신호 측정기술을 이용한 에센셜 오일 조성물의 향취 효능 검증방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150508

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150508

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160418

R150 Certificate of patent or registration of utility model

Ref document number: 5923469

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees